ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

BACKGROUND: Although aspirin is recommended for the prevention of colorectal cancer, the specific individuals for whom the benefits outweigh the risks are not clearly defined. Moreover, the precise mechanisms by which aspirin reduces the risk of cancer are unclear. We recently launched the ASPirin I...

Descripción completa

Detalles Bibliográficos
Autores principales: Drew, David A., Chin, Samantha M., Gilpin, Katherine K., Parziale, Melanie, Pond, Emily, Schuck, Madeline M., Stewart, Kathleen, Flagg, Meaghan, Rawlings, Crystal A., Backman, Vadim, Carolan, Peter J., Chung, Daniel C., Colizzo, Francis P., Freedman, Matthew, Gala, Manish, Garber, John J., Huttenhower, Curtis, Kedrin, Dmitriy, Khalili, Hamed, Kwon, Douglas S., Markowitz, Sanford D., Milne, Ginger L., Nishioka, Norman S., Richter, James M., Roy, Hemant K., Staller, Kyle, Wang, Molin, Chan, Andrew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286828/
https://www.ncbi.nlm.nih.gov/pubmed/28143522
http://dx.doi.org/10.1186/s13063-016-1744-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5286828/
https://www.ncbi.nlm.nih.gov/pubmed/28143522
http://dx.doi.org/10.1186/s13063-016-1744-z

Ejemplares similares